DUBLIN, Ohio — Cardinal Health announced on Thursday Debbie Weitzman, current president of Pharmaceutical Distribution, will become CEO of the company’s Pharmaceutical Segment. Weitzman will replace Victor Crawford, who will be stepping down as Pharmaceutical Segment CEO effective September 19, but will remain with the company until November 13 to help with the transition. The
With the pandemic surging, pharmacy chains are planning for new solutions to fight the variants. At the same time retailers are looking to broaden affordable and accessible health care offerings when many people find such services from more traditional providers out of financial reach. Chains are also bolstering their e-commerce appeal to entice omnichannel shoppers.
The pandemic has brought — in addition to peril — promise for pharmacy operators who have become central to testing and vaccination efforts. The impact of the crisis on pharmacy’s present and future, among other topics, was explored during a Chain Drug Review roundtable held virtually in conjunction with the NACDS Total Store Expo. Woldt:
Among the many changes wrought by the pandemic has been the heightened focus on diabetes management, given the increased risks to people with the condition. The implications for diabetes care from mass vaccinations and the waning of COVID-19 are discussed on the following pages by chain drug retailers and diabetes product suppliers. CDR: With so
The year that was like no other is over, and pharmacy operators are looking forward to more normal times, at least starting around summer. One question is how much the elevated status of pharmacists during the pandemic will propel long-term gains for the profession. On the following pages top industry executives address that question and
In this week’s installment of our Video Forum, Debbie Weitzman, president of U.S. Pharmaceutical Distribution at Cardinal Health, talks about the company’s commitment to supporting all aspects of the pharmacy profession. Among the subjects covered are Cardinal’s expanding range of capabilities, the health care system’s performance during the COVID-19 pandemic, and the benefits of allowing
DUBLIN, Ohio — More than 50% of hospital executives reported that health care industry pressures, along with the lack of time and resources, prohibit them from focusing on innovative initiatives for the hospital, according to a new Cardinal Health survey of hospital C-suite decision makers. And, more than two-thirds of respondents revealed that they don’t even consider
